title: Afatinib, a lung cancer inhibitor of ErbB family.
authors.affiliation: Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università 'Federico II' di Napoli, Naples, Italy, deantonellis@ceinge.unina.it.
authors.forename: Pasqualino
authors.initials: P
authors.lastname: de Antonellis
mesh_terms: D000077716:Afatinib; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D011799:Quinazolines / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D011799:Quinazolines; D000077716:Afatinib; D066246:ErbB Receptors
references.citation: Nat Med. 2012 Sep;18(9):1359-68
references.pmid: 22863786
references.citation: Proc Natl Acad Sci U S A. 2010 Aug 31;107(35):15535-40
references.pmid: 20713723
references.citation: Oncogene. 2014 Jul 17;33(29):3812-9
references.pmid: 23995783
references.citation: J Clin Oncol. 2013 Sep 20;31(27):3342-50
references.pmid: 23816967
references.citation: J Pharmacol Exp Ther. 2012 Nov;343(2):342-50
references.pmid: 22888144
references.citation: Lung Cancer. 2012 Jul;77(1):2-8
references.pmid: 22281074
references.citation: J Clin Oncol. 2013 Nov 1;31(31):3987-96
references.pmid: 24101047
references.citation: Lancet. 2013 Aug 24;382(9893):709-19
references.pmid: 23972814
references.citation: J Clin Oncol. 2013 Sep 20;31(27):3327-34
references.pmid: 23816960
references.citation: Nat Rev Drug Discov. 2011 Apr;10(4):307-17
references.pmid: 21455239